These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37349339)

  • 41. A Deep Dive into the Pathology of Gray Platelet Syndrome: New Insights on Immune Dysregulation.
    Glembotsky AC; De Luca G; Heller PG
    J Blood Med; 2021; 12():719-732. PubMed ID: 34408521
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Generation and characterization of a human iPSC line SANi006-A from a Gray Platelet Syndrome patient.
    Aarts CEM; Varga E; Webbers S; Geissler J; von Lindern M; Kuijpers TW; van den Akker E
    Stem Cell Res; 2021 Aug; 55():102443. PubMed ID: 34237592
    [TBL] [Abstract][Full Text] [Related]  

  • 43. What did we learn from CTLA-4 insufficiency on the human immune system?
    Mitsuiki N; Schwab C; Grimbacher B
    Immunol Rev; 2019 Jan; 287(1):33-49. PubMed ID: 30565239
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multifocal gastric adenocarcinoma in a patient with LRBA deficiency.
    Bratanič N; Kovač J; Pohar K; Trebušak Podkrajšek K; Ihan A; Battelino T; Avbelj Stefanija M
    Orphanet J Rare Dis; 2017 Jul; 12(1):131. PubMed ID: 28720148
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pediatric-onset Evans syndrome: Heterogeneous presentation and high frequency of monogenic disorders including LRBA and CTLA4 mutations.
    Besnard C; Levy E; Aladjidi N; Stolzenberg MC; Magerus-Chatinet A; Alibeu O; Nitschke P; Blanche S; Hermine O; Jeziorski E; Landman-Parker J; Leverger G; Mahlaoui N; Michel G; Pellier I; Suarez F; Thuret I; de Saint-Basile G; Picard C; Fischer A; Neven B; Rieux-Laucat F; Quartier P;
    Clin Immunol; 2018 Mar; 188():52-57. PubMed ID: 29330115
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gray platelet syndrome: Novel mutations of the NBEAL2 gene.
    Bottega R; Nicchia E; Alfano C; Glembotsky AC; Pastore A; Bertaggia-Calderara D; Bisig B; Duchosal MA; Arbesú G; Alberio L; Heller PG; Savoia A
    Am J Hematol; 2017 Feb; 92(2):E20-E22. PubMed ID: 27870194
    [No Abstract]   [Full Text] [Related]  

  • 47. Exaggerated follicular helper T-cell responses in patients with LRBA deficiency caused by failure of CTLA4-mediated regulation.
    Alroqi FJ; Charbonnier LM; Baris S; Kiykim A; Chou J; Platt CD; Algassim A; Keles S; Al Saud BK; Alkuraya FS; Jordan M; Geha RS; Chatila TA
    J Allergy Clin Immunol; 2018 Mar; 141(3):1050-1059.e10. PubMed ID: 28601686
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CTLA4 Message Reflects Pathway Disruption in Monogenic Disorders and Under Therapeutic Blockade.
    Garcia-Perez JE; Baxter RM; Kong DS; Tobin R; McCarter M; Routes JM; Verbsky J; Jordan MB; Dutmer CM; Hsieh EWY
    Front Immunol; 2019; 10():998. PubMed ID: 31156616
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NBEAL2 (Neurobeachin-Like 2) Is Required for Retention of Cargo Proteins by α-Granules During Their Production by Megakaryocytes.
    Lo RW; Li L; Leung R; Pluthero FG; Kahr WHA
    Arterioscler Thromb Vasc Biol; 2018 Oct; 38(10):2435-2447. PubMed ID: 30354215
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Disorders of CTLA-4 expression, how they lead to CVID and dysregulated immune responses.
    Sun D; Heimall J
    Curr Opin Allergy Clin Immunol; 2019 Dec; 19(6):578-585. PubMed ID: 31573993
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Monogenic forms of common variable immunodeficiency and implications on target therapeutic approaches.
    Tessarin G; Baronio M; Lougaris V
    Curr Opin Allergy Clin Immunol; 2023 Dec; 23(6):461-466. PubMed ID: 37767915
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CTLA-4 Expression in CD4+ T Cells From Patients With LRBA Deficiency and Common Variable Immunodeficiency With No Known Monogenic Disease.
    Azizi G; Jamee M; Yazdani R; Bagheri Y; Fayyaz F; Jadidi-Niaragh F; Abolhassani H; Aghamohammadi A
    J Investig Allergol Clin Immunol; 2018 Dec; 28(6):422-424. PubMed ID: 30530390
    [No Abstract]   [Full Text] [Related]  

  • 53. Should any genetic defect affecting α-granules in platelets be classified as gray platelet syndrome?
    Nurden AT; Nurden P
    Am J Hematol; 2016 Jul; 91(7):714-8. PubMed ID: 26971401
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of novel pathogenic F13A1 mutation and novel NBEAL2 gene missense mutation in a pedigree with hereditary congenital factor XIII deficiency.
    Jia S; He Y; Lu M; Liao N; Lei Y; Lauriane N; Liang K; Wei H
    Gene; 2019 Jun; 702():143-147. PubMed ID: 30935919
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immune dysregulation, autoimmunity, and granule defects in gray platelet syndrome.
    Collins JH; Mayer L; Guerrero Lopez JA
    J Thromb Haemost; 2023 Jun; 21(6):1409-1419. PubMed ID: 37028650
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The α-granule proteome: novel proteins in normal and ghost granules in gray platelet syndrome.
    Maynard DM; Heijnen HF; Gahl WA; Gunay-Aygun M
    J Thromb Haemost; 2010 Aug; 8(8):1786-96. PubMed ID: 20524979
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Case of Chronic Thrombocytopenia in a 17-Year-Old Female.
    Riley R; Khan A; Pai S; Warmke L; Winkler M; Gunning W
    Lab Med; 2019 Oct; 50(4):406-420. PubMed ID: 31228350
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CTLA-4 regulates T follicular regulatory cell differentiation and participates in intestinal damage caused by spontaneous autoimmunity.
    Chao G; Li X; Ji Y; Zhu Y; Li N; Zhang N; Feng Z; Niu M
    Biochem Biophys Res Commun; 2018 Nov; 505(3):865-871. PubMed ID: 30301533
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CTLA-4: From mechanism to autoimmune therapy.
    Hosseini A; Gharibi T; Marofi F; Babaloo Z; Baradaran B
    Int Immunopharmacol; 2020 Mar; 80():106221. PubMed ID: 32007707
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Early-onset Crohn's disease and autoimmunity associated with a variant in CTLA-4.
    Zeissig S; Petersen BS; Tomczak M; Melum E; Huc-Claustre E; Dougan SK; Laerdahl JK; Stade B; Forster M; Schreiber S; Weir D; Leichtner AM; Franke A; Blumberg RS
    Gut; 2015 Dec; 64(12):1889-97. PubMed ID: 25367873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.